Managing Chronic Pain in Adults with Substance Use Disorders



Similar documents
COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Knowing the Facts About Medication Adherence Among Those with Serious Mental Illness

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Southlake Psychiatry. Suboxone Contract

Drug Testing to Support Pain Management

Prescription Medication Abuse: Skills for Prevention and Intervention

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Benzodiazepine Detoxification and Reduction of Long term Use

Opioid Agreement for Center for Pain Management S.C.

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

Naltrexone and Alcoholism Treatment Test

Fraud, Waste and Abuse

Iowa Governor s Office of Drug Control Policy

Screening Patients for Substance Use in Your Practice Setting

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Opioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015

TREATMENT-RESISTANT DEPRESSION AND ANXIETY

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Prescribing and Tapering Benzodiazepines

Information for Pharmacists

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

Considerations when Using Controlled Substances to Treat Chronic Pain

Chronic Opioid Use: Comparison of Current Guidelines

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Medications for chronic pain

The Addicted Brain. And what you can do

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

When The Long Term Use of Narcotics for Pain Management Becomes the Problem:

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Blueprint for Prescriber Continuing Education Program

The Journal of the Oklahoma State Medical Association

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Arkansas Emergency Department Opioid Prescribing Guidelines

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

Frequently Asked Questions About Prescription Opioids

Sample Patient Agreement Forms

Test Content Outline Effective Date: June 9, Pain Management Nursing Board Certification Examination

Opioid Treatment Agreement

SUMMARY OF RECOMMENDATIONS

Appropriate Use of UDT to Improve Patient Care

PRESCRIPTION DRUG ABUSE prevention

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

Karol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University

Abstral Prescriber and Pharmacist Guide

1. According to recent US national estimates, which of the following substances is associated

Science and Treatment Prescription Drug Addiction Treatment. Karen Miotto, M.D. David Geffen School of Medicine

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Arizona opioid PrescRibing guidelines

DrugFacts: Treatment Approaches for Drug Addiction

OPIOID PAIN MEDICATION Agreement and Informed Consent

MEDICATION ABUSE IN OLDER ADULTS

SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)

Guidelines for Use of Controlled Substances for the Treatment of Pain

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright and How is it Treated?

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

Treatment Approaches for Drug Addiction

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer

Frequently asked questions

Alcohol Overuse and Abuse

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Assessment of depression in adults in primary care

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Opioid/Opiate Dependent Pregnant Women

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones

Transcription:

Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which is NOT one of the 3Cs of addiction? a) Coercive behaviors b) Control c) Continued use d) Craving 3) Chronic pain syndrome involves intractable pain of or longer. a) 3 months b) 6 months c) 9 months d) 12 months 4) Pain is evaluated in the a) Dorsal horn b) Limbic system c) Somatosensory cortex d) Thalamic nuclei 5) Pain caused by sickle cell disease is described as which type of pain? a) Acute b) Acute intermittent c) Chronic d) Chronic intermittent 6) In the reward response, feelings of reward emerge from the core of the limbic system after neurons in the ventral tegmental area release the neurotransmitter a) Dopamine b) Serotonin c) Histamine d) Melatonin

7) NIDA (2007) estimates that between of a person s vulnerability to addiction may be genetic. a) 10 to 20% b) 20 to 40% c) 40 to 60% d) 60 to 70% 8) People with alcohol use disorders have been found to be more than times as likely to report nonmedical use of prescription medications as people who do not drink. a) 18 b) 24 c) 30 d) 36 Question from chapter 2 9) Because of their accuracy, standardized tools should be the absolute determinant of treatments offered or withheld. a) True b) False 10) Clinicians are especially likely to underestimate and undertreat pain and disability in all the following EXCEPT a) Elderly b) Men c) Minorities d) People with SUDs 11) Which tool to assess pain level is subject to measurement error? a) Faces Pain Scale b) Numeric Rating Scale c) McGill Pain Questionnaire d) Visual Analog Scale 12) Which is a tool to assess several dimensions of pain? a) Faces Pain Scale b) Numeric Rating Scale c) McGill Pain Questionnaire d) Visual Analog Scale

13) According to the NIAAA (2005), if a female patient has more than drinks per week, she is at increased risk for developing alcohol-related problems. a) 5 b) 7 c) 10 d) 14 14) Which tool has 24 yes/no questions and takes 10 minutes to administer? a) Drug Abuse Screening Test b) MAST c) AUDIT d) CAGE 15) Which can present as depression? a) Sleep apnea b) Hypothyroidism c) Hypogonadism d) All of the above 16) Many patients who have multiple unexplained symptoms have subsyndromal forms of a) Somatization disorder b) PTSD c) Personality disorder d) Depression 17) Patients who have chronic pain who score on measures of selfefficacy or have an locus of control report lower levels of pain, higher pain thresholds, increased exercise performance, and more positive coping efforts. a) Low, Internal b) Low, External c) High, Internal d) High, External 18) A score of or higher on the SOAPP-R suggests the patient is at high risk for problems with chronic opioid therapy. a) 5 b) 9 c) 15 d) 18

Question from chapter 3 19) The complete elimination of pain for a substantial period is the goal of pain management. a) True b) False 20) The primary adjuvant analgesics are a) Antipsychotics and Anxiolytics b) Anxiolytics and Antidepressants c) Antidepressants and Anticonvulsants d) Anticonvulsants and Antipsychotics 21) Which analgesic is addictive? a) Anticonvulsants b) Topical Analgesics c) Antipsychotics d) Benzodiazepines 22) Which is NOT a common nonpharmacological therapy for CNCP. a) Physical therapy b) Synthetic THC c) Cognitive behavioral therapy d) Complementary and alternative medicine 23) Van Ameringen and colleagues (2004) found the strongest evidence for the use of for panic disorder. a) Valproic acid b) Gabapentin c) Lamotrigine d) Pregabalin 24) Which is a limitation of opioid therapy? a) Diminished efficacy over time b) Adverse effects that many patients cannot tolerate c) Risk of addiction d) All the above 25) The majority of deaths secondary to methadone occur in the first 14 days of use because of all the following reasons EXCEPT a) The initial dose is too high b) It is titrated too quickly c) The patient has an undiagnosed cardiac condition d) It interacts with other drugs or medications

26) Patients who have chronic pain do not obtain adequate pain control through a single daily dose of methadone. a) True b) False 27) The most common opioid rotation is a) Oxycodone to Hydrocodone b) Hydrocodone to Morphine c) Morphine to Methadone d) Methadone to Oxycodone Question from chapter 4 28) In the context of pain treatment, a approach refers to a minimum standard of care applied to all patients who have CNCP, whatever their assessed risk. a) Manualized b) Evidence Based Practice c) Consumer based d) Universal precautions 29) Couto et al. (2009) studied data from the urine tests of 900,000 patients on chronic opioid treatment and found that of the patients showed at least one sign of nonadherence to opioid regimens. a) 55% b) 65% c) 75% d) 85% 30) Heit and Gourlay (2004) recommended testing for all the following substances during routine screening EXCEPT a) Alcohol b) Cocaine c) Methadone d) Marijuana 31) Behavior that suggests substance misuse, abuse, or addiction is known as a) Proneness to abuse b) Abuse markers c) Rule-outs d) Aberrant drug-related behavior

32) Which tool helps determine whether opioids have become a problem for the patient? a) Current Opioid Misuse Measure b) Opioid Abuse Survey c) Addiction Behaviors Checklist d) Survey of Opioid Use 33) Which tool asks patients about their behavior in the 30 days before the appointment? a) Current Opioid Misuse Measure b) Opioid Abuse Survey c) Addiction Behaviors Checklist d) Survey of Opioid Use 34) Which is NOT recommended as an activity which can help build a therapeutic relationship between the treatment team and the patient? a) Listening actively b) Using thinking statements c) Using clarification statements d) Demonstrating empathy 35) Medications taken by people other than for whom they are prescribed are said to be a) Boosted b) Off label c) Spanked d) Diverted 36) Symptoms of opioid withdrawal include all EXCEPT a) Bone and muscle pain b) Fever c) Anxiety d) Insomnia Question from chapter 5 37) The capacity to capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions is known as a) Patient competence b) Instructional validity c) Health literacy d) Patient rights

38) Schillinger et al. (2003) suggests that communication can be enhanced by using the method. a) Simon says b) Reflective listening c) Teach-back d) Parrot 39) The VA/DoD (2010) states that patients need to understand all the following about opioids EXCEPT a) The titration process b) The risks of discontinuing the medication abruptly c) How medication will be safely discontinued d) That hyperactivity is a common side effect during titration 40) Which is a common element of a treatment agreement? a) Limits on medication refills b) Consent for random urine drug testing and other specified testing c) Required pill counts d) All the above